CAR-T 细胞在肿瘤治疗中的研究进展
赵玲娣， 高全立 - 中国肿瘤临床, 2015 - cjco.cn
… CARs in chronic lympho⁃ cytic leukemia-ready to drive[J]. Curr Hematol Malig Rep, 2013,
8 … Efficacy and toxicity manage⁃ ment of 19-28z CAR T cell therapy in B cell acute …
8 … Efficacy and toxicity manage⁃ ment of 19-28z CAR T cell therapy in B cell acute …
人表皮生长因子受体2 靶向特异性T 细胞治疗胃癌的前沿进展
杨彩霞， 尚轶 - 中华普通外科学文献(电子版), 2020 - zhptwkxwx.cma-cmc.com.cn
… biology and genetic engineering technology, human epidermal growth factor receptor 2 (HER-2)-specific
chimeric antigen receptor T cell (CAR-T), a new model of adoptive immune …
chimeric antigen receptor T cell (CAR-T), a new model of adoptive immune …
CAR-T 治疗急性白血病患者严重并发症CRS 与CRES 救治的规范化护理
张佳思， 谭方方， 袁嘉， 符刚， 阮潜瑛， 姜盛， 黎诗琦… - 临床输血与检验, 2021 - lcsxyjy.com
… Conclusion Early judgment and nursing intervention could alleviate the complication of
CAR-T cell therapy and improve the rescue rate. [Key words] CAR-T cell therapy Acute …
CAR-T cell therapy and improve the rescue rate. [Key words] CAR-T cell therapy Acute …
CAR-T 治疗B 细胞淋巴瘤不良反应的Meta 分析
K Xun, Z Xiyou, C Feng, LI Dandan, D Qianqian… - 中国癌症 …, 2019 - china-oncology.com
… , LU T, et al. Lymphoma remissions caused by anti-CD19 chimeric antigen receptor T cells
… CAR T cells: driving the road from the laboratory to the clinic[J]. Immunol Rev, 2014, 257(1): …
… CAR T cells: driving the road from the laboratory to the clinic[J]. Immunol Rev, 2014, 257(1): …
嵌合抗原受体T 细胞治疗多形性胶质母细胞瘤的最新进展
白玥， 钟晓松， 李文斌 - 中国肿瘤临床, 2017 - cjco.cn
… CAR-T cell therapy in the treatment of GBM. Keywords: glioblastoma multiforme, chimeric
antigen receptor T-cell… CAR T cells:driving the road from the laboratory to the clinic[J]. Immunol …
antigen receptor T-cell… CAR T cells:driving the road from the laboratory to the clinic[J]. Immunol …
[HTML][HTML] 靶向HER2 的CAR-T 细胞构建与抗肿瘤活性的体外分析
李永强， 姚崧源， 李延胜， 徐明恺， 张惠文， 张成刚 - 生物工程学报, 2018 - cjb.ijournals.cn
… -generation HER2-specific CAR-T cells specifically suppressed growth of tumor cells
overexpressing HER2 protein, suggesting that HER2-specific CAR-T cells might prove useful for …
overexpressing HER2 protein, suggesting that HER2-specific CAR-T cells might prove useful for …
嵌合抗原受体T 细胞免疫疗法在B 细胞非霍奇金淋巴瘤中的研究进展.
赵培起， 张会来 - Tianjin Medical Journal, 2020 - search.ebscohost.com
… Research progress of chimeric antigen receptor T cell immunotherapy in B-cell non-… B-cell
NHL. At present, Food and Drug Administration (FDA) has approved two CAR-T cell therapy …
NHL. At present, Food and Drug Administration (FDA) has approved two CAR-T cell therapy …
重度哮喘的生物与细胞疗法研究进展
徐芳， 田国雄， 孙倍倍， 陈馨怡， 陈高莹… - 山东大学学报 …, 2024 - yxbwk.njournal.sdu.edu.cn
… In recent years, studies have also pioneered the application of novel cellular therapies, such
as stem cell therapy or chimeric antigen receptor T(CAR-T)cell therapy, to the treatment of …
as stem cell therapy or chimeric antigen receptor T(CAR-T)cell therapy, to the treatment of …
肿瘤细胞免疫治疗相关伦理学探讨
S Ren, J Deng, M Hong, Y Ren, H Fu, Y Liu… - Journal of Zhejiang …, 2019 - Springer
… activated T cells can secrete cytokines and promote T cell … abide by standardized laboratory
management requirements. … Chimeric antigen receptor T cells for sustained remissions in …
management requirements. … Chimeric antigen receptor T cells for sustained remissions in …
不同信号肽对嵌合抗原受体T 细胞杀伤作用的影响研究
李帆， 张琴星， 童祥文， 田高辉， 顾力行， 徐瑶 - 中国癌症杂志, 2022 - china-oncology.com
… -CAR expression of four different SP on the surface of T cells and their effect on the killing of
CD19+ target cells. … CAR T cells: driving the road from the laboratory to the clinic[J]. Immunol …
CD19+ target cells. … CAR T cells: driving the road from the laboratory to the clinic[J]. Immunol …